Advisory Committee on Childhood Lead Poisoning Prevention, 64997 [2012-26274]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 206 / Wednesday, October 24, 2012 / Notices
of Compensation Analysis and Support,
NIOSH, 4676 Columbia Parkway, MS C–
46, Cincinnati, OH 45226, Telephone 1–
877–222–7570. Information requests can
also be submitted by email to
DCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2012–26172 Filed 10–23–12; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Childhood
Lead Poisoning Prevention
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Times and Dates
9:00 a.m.–4:00 p.m., November 14, 2012
8:45 a.m.–4:30 p.m., November 15, 2012
9:15 a.m.–12:00 p.m., November 16,
2012
Place: CDC, Chamblee Campus,
Building 106, 1st Floor, Conference
Rooms 1A/B, 4770 Buford Highway,
NE., Atlanta, Georgia 30341.
Status
This meeting is open to the public,
limited only by the space available. The
meeting room accommodates
approximately 75 people. Opportunities
will be provided during the meeting for
oral comments.
free policies in public housing;
Laboratory Workgroup updates;
Educational Intervention Workgroup
presentation; Agency updates and
Response to ACCLPP
Recommendations; Federal agency
updates; HUD Guidelines (Second
Edition); Lead-based paint/hazards
standard review; Spot Test Kit update
and international work.
Agenda items are subject to change as
priorities dictate.
Supplemental Information: The
public comment period is scheduled on
Wednesday, November 14, 2012, from
3:45 p.m.–4:00 p.m.; on Thursday,
November 15, 2012, from 4:15 p.m.–4:30
p.m.; and on Friday, November 16,
2012, from 11:45 a.m.–12:00 p.m.
Contact Person for More Information
Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR,
CDC, 4770 Buford Highway, Mail Stop
F–61, Chamblee, Georgia 30345,
Telephone: (770) 488–0575, Fax: (770)
488–3377, Email: smalcom@cdc.gov.
The deadline for notification of
attendance is November 9, 2012.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: October 17, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–26274 Filed 10–23–12; 8:45 am]
BILLING CODE 4163–18–P
Purpose
The Committee provides advice and
guidance to the Secretary; the Assistant
Secretary for Health; and the Director,
CDC, regarding new scientific
knowledge and technological
developments and their practical
implications for childhood lead
poisoning prevention efforts. The
committee also reviews and reports
regularly on childhood lead poisoning
prevention practices and recommends
improvements in national childhood
lead poisoning prevention efforts.
wreier-aviles on DSK5TPTVN1PROD with
Matters To Be Discussed
Agenda items will include the
following: Childhood Lead Poisoning
Prevention Update—Status of our 35
Programs; evaluation of services for
children in Chicago; scientific program
presentation costs and benefits of smoke
VerDate Mar<15>2010
14:21 Oct 23, 2012
Jkt 229001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3275–N]
Medicare Program; Meeting of the
Medicare Evidence Development and
Coverage Advisory Committee—
January 30, 2013
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces that a
public meeting of the Medicare
Evidence Development & Coverage
Advisory Committee (MEDCAC)
(‘‘Committee’’) will be held on
Wednesday, January 30, 2013. The
SUMMARY:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
64997
Committee generally provides advice
and recommendations concerning the
adequacy of scientific evidence needed
to determine whether certain medical
items and services can be covered under
the Medicare statute. This meeting will
focus on beta amyloid positron emission
tomography in dementia and
neurodegenerative disease. This meeting
is open to the public in accordance with
the Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)).
DATES: Meeting Date: The public
meeting will be held on Wednesday,
January 30, 2013 from 7:30 a.m. until
4:30 p.m., Eastern Standard Time (EST).
Deadline for Submission of Written
Comments: Written comments must be
received at the address specified in the
ADDRESSES section of this notice by 5
p.m., EST, Monday, December 17, 2012.
Once submitted, all comments are final.
Deadlines for Speaker Registration
and Presentation Materials: The
deadline to register to be a speaker and
to submit PowerPoint presentation
materials and writings that will be used
in support of an oral presentation is 5:00
p.m., EST on Monday, December 17,
2012. Speakers may register by phone or
via email by contacting the person listed
in the FOR FURTHER INFORMATION
CONTACT section of this notice.
Presentation materials must be received
at the address specified in the
ADDRESSES section of this notice.
Deadline for All Other Attendees
Registration: Individuals may register
online at https://www.cms.gov/apps/
events/upcomingevents.asp?strOrder
By=1&type=3 or by phone by contacting
the person listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice by 5 p.m. EST, Wednesday,
January 23, 2013.
We will be broadcasting the meeting
live via Webcast at https://www.cms.gov/
live/.
Deadline for Submitting a Request for
Special Accommodations: Persons
attending the meeting who are hearing
or visually impaired, or have a
condition that requires special
assistance or accommodations, are
asked to contact the Executive Secretary
as specified in the FOR FURTHER
INFORMATION CONTACT section of this
notice no later than 5:00 p.m., EST
Friday, January 11, 2013.
ADDRESSES: Meeting Location: The
meeting will be held in the main
auditorium of the Centers for Medicare
& Medicaid Services, 7500 Security
Boulevard, Baltimore, MD 21244.
Submission of Presentations and
Comments: Presentation materials and
written comments that will be presented
at the meeting must be submitted via
E:\FR\FM\24OCN1.SGM
24OCN1
]]>Agencies
[Federal Register Volume 77, Number 206 (Wednesday, October 24, 2012)]
[Notices]
[Page 64997]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26274]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Childhood Lead Poisoning Prevention
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Times and Dates
9:00 a.m.-4:00 p.m., November 14, 2012
8:45 a.m.-4:30 p.m., November 15, 2012
9:15 a.m.-12:00 p.m., November 16, 2012
Place: CDC, Chamblee Campus, Building 106, 1st Floor, Conference
Rooms 1A/B, 4770 Buford Highway, NE., Atlanta, Georgia 30341.
Status
This meeting is open to the public, limited only by the space
available. The meeting room accommodates approximately 75 people.
Opportunities will be provided during the meeting for oral comments.
Purpose
The Committee provides advice and guidance to the Secretary; the
Assistant Secretary for Health; and the Director, CDC, regarding new
scientific knowledge and technological developments and their practical
implications for childhood lead poisoning prevention efforts. The
committee also reviews and reports regularly on childhood lead
poisoning prevention practices and recommends improvements in national
childhood lead poisoning prevention efforts.
Matters To Be Discussed
Agenda items will include the following: Childhood Lead Poisoning
Prevention Update--Status of our 35 Programs; evaluation of services
for children in Chicago; scientific program presentation costs and
benefits of smoke free policies in public housing; Laboratory Workgroup
updates; Educational Intervention Workgroup presentation; Agency
updates and Response to ACCLPP Recommendations; Federal agency updates;
HUD Guidelines (Second Edition); Lead-based paint/hazards standard
review; Spot Test Kit update and international work.
Agenda items are subject to change as priorities dictate.
Supplemental Information: The public comment period is scheduled on
Wednesday, November 14, 2012, from 3:45 p.m.-4:00 p.m.; on Thursday,
November 15, 2012, from 4:15 p.m.-4:30 p.m.; and on Friday, November
16, 2012, from 11:45 a.m.-12:00 p.m.
Contact Person for More Information
Sandra Malcom, Committee Management Specialist, NCEH/ATSDR, CDC,
4770 Buford Highway, Mail Stop F-61, Chamblee, Georgia 30345,
Telephone: (770) 488-0575, Fax: (770) 488-3377, Email: smalcom@cdc.gov.
The deadline for notification of attendance is November 9, 2012.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: October 17, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-26274 Filed 10-23-12; 8:45 am]
BILLING CODE 4163-18-P
